200 related articles for article (PubMed ID: 34246313)
1. Clinical, molecular and glycophenotype insights in SLC39A8-CDG.
Bonaventura E; Barone R; Sturiale L; Pasquariello R; Alessandrì MG; Pinto AM; Renieri A; Panteghini C; Garavaglia B; Cioni G; Battini R
Orphanet J Rare Dis; 2021 Jul; 16(1):307. PubMed ID: 34246313
[TBL] [Abstract][Full Text] [Related]
2. N-glycome analysis detects dysglycosylation missed by conventional methods in SLC39A8 deficiency.
Park JH; Mealer RG; Elias AF; Hoffmann S; Grüneberg M; Biskup S; Fobker M; Haven J; Mangels U; Reunert J; Rust S; Schoof J; Schwanke C; Smoller JW; Cummings RD; Marquardt T
J Inherit Metab Dis; 2020 Nov; 43(6):1370-1381. PubMed ID: 32852845
[TBL] [Abstract][Full Text] [Related]
3. A SLC39A8 variant causes manganese deficiency, and glycosylation and mitochondrial disorders.
Riley LG; Cowley MJ; Gayevskiy V; Roscioli T; Thorburn DR; Prelog K; Bahlo M; Sue CM; Balasubramaniam S; Christodoulou J
J Inherit Metab Dis; 2017 Mar; 40(2):261-269. PubMed ID: 27995398
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
[TBL] [Abstract][Full Text] [Related]
5. MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.
Palmigiano A; Bua RO; Barone R; Rymen D; Régal L; Deconinck N; Dionisi-Vici C; Fung CW; Garozzo D; Jaeken J; Sturiale L
J Mass Spectrom; 2017 Jun; 52(6):372-377. PubMed ID: 28444691
[TBL] [Abstract][Full Text] [Related]
6. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
[TBL] [Abstract][Full Text] [Related]
7. The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylation.
Mealer RG; Jenkins BG; Chen CY; Daly MJ; Ge T; Lehoux S; Marquardt T; Palmer CD; Park JH; Parsons PJ; Sackstein R; Williams SE; Cummings RD; Scolnick EM; Smoller JW
Sci Rep; 2020 Aug; 10(1):13162. PubMed ID: 32753748
[TBL] [Abstract][Full Text] [Related]
8. Dolichol kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation.
Helander A; Stödberg T; Jaeken J; Matthijs G; Eriksson M; Eggertsen G
Mol Genet Metab; 2013 Nov; 110(3):342-4. PubMed ID: 23890587
[TBL] [Abstract][Full Text] [Related]
9. Clinical, biochemical and molecular phenotype of congenital disorders of glycosylation: long-term follow-up.
Bogdańska A; Lipiński P; Szymańska-Rożek P; Jezela-Stanek A; Rokicki D; Socha P; Tylki-Szymańska A
Orphanet J Rare Dis; 2021 Jan; 16(1):17. PubMed ID: 33407696
[TBL] [Abstract][Full Text] [Related]
10. SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation.
Park JH; Hogrebe M; Grüneberg M; DuChesne I; von der Heiden AL; Reunert J; Schlingmann KP; Boycott KM; Beaulieu CL; Mhanni AA; Innes AM; Hörtnagel K; Biskup S; Gleixner EM; Kurlemann G; Fiedler B; Omran H; Rutsch F; Wada Y; Tsiakas K; Santer R; Nebert DW; Rust S; Marquardt T
Am J Hum Genet; 2015 Dec; 97(6):894-903. PubMed ID: 26637979
[TBL] [Abstract][Full Text] [Related]
11. Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients.
Vals MA; Ashikov A; Ilves P; Loorits D; Zeng Q; Barone R; Huijben K; Sykut-Cegielska J; Diogo L; Elias AF; Greenwood RS; Grunewald S; van Hasselt PM; van de Kamp JM; Mancini G; Okninska A; Pajusalu S; Rudd PM; Rustad CF; Salvarinova R; de Vries BBA; Wolf NI; ; Ng BG; Freeze HH; Lefeber DJ; Õunap K
J Inherit Metab Dis; 2019 May; 42(3):553-564. PubMed ID: 30746764
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG.
Witters P; Tahata S; Barone R; Õunap K; Salvarinova R; Grønborg S; Hoganson G; Scaglia F; Lewis AM; Mori M; Sykut-Cegielska J; Edmondson A; He M; Morava E
Genet Med; 2020 Jun; 22(6):1102-1107. PubMed ID: 32103184
[TBL] [Abstract][Full Text] [Related]
13. Galactose Supplementation in Patients With TMEM165-CDG Rescues the Glycosylation Defects.
Morelle W; Potelle S; Witters P; Wong S; Climer L; Lupashin V; Matthijs G; Gadomski T; Jaeken J; Cassiman D; Morava E; Foulquier F
J Clin Endocrinol Metab; 2017 Apr; 102(4):1375-1386. PubMed ID: 28323990
[TBL] [Abstract][Full Text] [Related]
14. DDOST-CDG: Clinical and molecular characterization of a third patient with a milder and a predominantly movement disorder phenotype.
Elsharkawi I; Wongkittichote P; Daniel EJP; Starosta RT; Ueda K; Ng BG; Freeze HH; He M; Shinawi M
J Inherit Metab Dis; 2023 Jan; 46(1):92-100. PubMed ID: 36214423
[TBL] [Abstract][Full Text] [Related]
15. SLC39A8 gene encoding a metal ion transporter: discovery and bench to bedside.
Nebert DW; Liu Z
Hum Genomics; 2019 Sep; 13(Suppl 1):51. PubMed ID: 31521203
[TBL] [Abstract][Full Text] [Related]
16. Serum N-glycomics of a novel CDG-IIb patient reveals aberrant IgG glycosylation.
Beimdiek J; Hennig R; Burock R; Puk O; Biskup S; Rapp E; Lesinski-Schiedat A; Buettner FFR; Das AM
Glycobiology; 2022 Apr; 32(5):380-390. PubMed ID: 35137040
[TBL] [Abstract][Full Text] [Related]
17. A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation.
Barone R; Carrozzi M; Parini R; Battini R; Martinelli D; Elia M; Spada M; Lilliu F; Ciana G; Burlina A; Leuzzi V; Leoni M; Sturiale L; Matthijs G; Jaeken J; Di Rocco M; Garozzo D; Fiumara A
J Neurol; 2015 Jan; 262(1):154-64. PubMed ID: 25355454
[TBL] [Abstract][Full Text] [Related]
18. Novel ALG12 variants and hydronephrosis in siblings with impaired N-glycosylation.
Hiraide T; Wada Y; Matsubayashi T; Kadoya M; Masunaga Y; Ohkubo Y; Nakashima M; Okamoto N; Ogata T; Saitsu H
Brain Dev; 2021 Oct; 43(9):945-951. PubMed ID: 34092405
[TBL] [Abstract][Full Text] [Related]
19. Normal transferrin patterns in congenital disorders of glycosylation with Golgi homeostasis disruption: apolipoprotein C-III at the rescue!
Raynor A; Vincent-Delorme C; Alaix AS; Cholet S; Dupré T; Vuillaumier-Barrot S; Fenaille F; Besmond C; Bruneel A
Clin Chim Acta; 2021 Aug; 519():285-290. PubMed ID: 34022244
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
